Ombudsman: Quick resolution to complaints in 2006
This article was originally published in The Silver Sheet
Executive Summary
Issues surrounding product adverse events, FDA inspections, warning letters and the Quality System Regulation accounted for 12 percent of complaints filed with CDRH's ombudsman last year, according to a recently published annual report. Ombudsman Les Weinstein received a total of 120 complaints from device manufacturers and others last year - roughly the same as in the previous three years. Eighty-one percent of the cases on Weinstein's desk last year were resolved. The resolution rate was significantly lower in prior years: 33 percent in 2005, 31 percent in 2004 and 26 percent in 2003. "Last year, a lot of cases to be resolved could be resolved quickly," Weinstein says. In addition, a number of cases that came to Weinstein's attention in 2004 and 2005 were finally resolved in 2006. As in previous years, "miscommunication" or "lack of communication" was the No. 1 reason for gripes to the ombudsman in 2006
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.